Citalopram versus other selective serotonin-reuptake inhibitors

American Journal of Health-System Pharmacy

Volumn 56, Issue 21, 1999, Pages 2242-2244

  Thomas, Kimberly V ^a   Holimon, Teresa D ^a  

^a UNIVERSITY OF TENNESSEE HEALTH SCIENCE CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CITALOPRAM; FLUOXETINE; FLUVOXAMINE; SEROTONIN UPTAKE INHIBITOR; SERTRALINE; UNCLASSIFIED DRUG;

DEPRESSION; DIARRHEA; DRUG EFFICACY; DRUG INDICATION; DRUG INDUCED DISEASE; HUMAN; NAUSEA; NOTE; PRIORITY JOURNAL; VOMITING;

EID: 0033230234     PISSN: 10792082     EISSN: None     Source Type: Journal    
DOI: 10.1093/ajhp/56.21.2242     Document Type: Note

References (4)

1. Patris M, Bouchard JM, Bougerol T et al. Citalopram versus fluoxetine: a double blind, multicentre, Phase III trial in patients with unipolar major depression treated in general practice. Int Clin Psychopharm. 1996; 11:129-36.
2. Kasper S, Fuger J, Moller HJ. Comparative efficacy of antidepressants. Drugs. 1992; 43:S11-9.
3. Ekselius L, von Knorring L, Eberhard G. A double-blind multicenter trial comparing sertraline and citalopram in patients with major depression treated in general practice. Int Clin Psychopharm. 1997; 12:323-31.
4. Haffmans PMJ, Timmerman L, Hoogduin CAL et al. Efficacy and tolerability of citalopram with fluvoxamine in depressed outpatients: a double blind, multicentre study. Int Clin Psychopharm. 1996; 11:157-64.